SJ

Seshajalam Jeevarathinam

Active Director Director DIN 10213650
DIN 10213650 First appointment Jun 2023 Primary industry Research & Development
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jun 2023
Shareholding value β€’β€’β€’β€’ Premium profile

About Seshajalam Jeevarathinam

Data last updated:

Seshajalam Jeevarathinam is a Director at Peptobiotics India Private Limited (since 2023). The company operates in Research & Development.

DIN 10213650
Primary Designation Director
Industry Research & Development
First Appointment 26 Jun 2023
Oldest Company Age 3 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Peptobiotics India Private Limited U73200KA2022FTC169712
Director26 Jun 20232022Active

Board colleagues of Seshajalam Jeevarathinam

NameDINCompanyDesignation
Jonathan Bester10077000Peptobiotics India Private LimitedDirector

Directorship timeline

Open interactive timeline →
Peptobiotics India Private Limited
Premium access

Shareholding and investment profile for Seshajalam Jeevarathinam

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Seshajalam Jeevarathinam

Seshajalam Jeevarathinam currently holds 1 directorship: Peptobiotics India Private Limited (Director, since 26 Jun 2023).

Seshajalam Jeevarathinam was first appointed on 26 Jun 2023 as Director at Peptobiotics India Private Limited.

The current boards of Seshajalam Jeevarathinam's companies include Jonathan Bester (Peptobiotics India Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available